These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 526932

  • 1. Phase I study of anguidine administered weekly.
    Belt RJ, Haas CD, Joseph U, Goodwin W, Moore D, Hoogstraten B.
    Cancer Treat Rep; 1979; 63(11-12):1993-5. PubMed ID: 526932
    [Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of anguidine (NSC-141537) for adenocarcinoma of the colon or rectum.
    Diggs CH, Scoltock MJ, Wiernik PH.
    Cancer Clin Trials; 1978; 1(4):297-9. PubMed ID: 757146
    [Abstract] [Full Text] [Related]

  • 3. Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal Malignancies.
    DeSimone PA, Greco FA, Lessner HF.
    Cancer Treat Rep; 1979; 63(11-12):2015-7. PubMed ID: 526934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase I clinical evaluation of anguidine.
    Murphy WK, Burgess MA, Valdivieso M, Livingston RB, Bodey GP, Freireich EJ.
    Cancer Treat Rep; 1978 Oct; 62(10):1497-502. PubMed ID: 361224
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II study of anguidine in gastrointestinal malignancies: a Southwest Oncology Group study.
    Bukowski R, Vaughn C, Bottomley R, Chen T.
    Cancer Treat Rep; 1982 Feb; 66(2):381-3. PubMed ID: 7055820
    [Abstract] [Full Text] [Related]

  • 8. Phase I trial of bruceantin.
    Garnick MB, Blum RH, Canellos GP, Mayer RJ, Parker L, Skarin AT, Li FP, Henderson IC, Frei E.
    Cancer Treat Rep; 1979 Feb; 63(11-12):1929-32. PubMed ID: 526926
    [Abstract] [Full Text] [Related]

  • 9. Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group Trial.
    DeSimone PA, Greco FA, Lessner HF, Bartolucci A.
    Am J Clin Oncol; 1986 Jun; 9(3):187-8. PubMed ID: 3728370
    [Abstract] [Full Text] [Related]

  • 10. Phase II evaluation of anguidine in central nervous system tumors: a southwest Oncology Group study.
    Goodwin JW, Bottomley RH, Vaughn CB, Frank J, Pugh RP.
    Cancer Treat Rep; 1983 Mar; 67(3):285-6. PubMed ID: 6831475
    [No Abstract] [Full Text] [Related]

  • 11. Initial clinical studies with bruceantin.
    Bedikian AY, Valdivieso M, Bodey GP, Murphy WK, Freireich EJ.
    Cancer Treat Rep; 1979 Mar; 63(11-12):1843-7. PubMed ID: 526918
    [Abstract] [Full Text] [Related]

  • 12. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 13. Anguidine: a broad phase II study of the Southeastern Cancer Study Group.
    Adler SS, Lowenbraun S, Birch B, Jarrell R, Garrard J.
    Cancer Treat Rep; 1984 Feb; 68(2):423-5. PubMed ID: 6697331
    [Abstract] [Full Text] [Related]

  • 14. Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.
    Löffler TM, Freund W, Lipke J, Hausamen TU.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):32-4. PubMed ID: 9007118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The acute toxicopathy of intravenous diacetoxyscirpenol (anguidine) administration in swine.
    Coppock RW, Gelberg HB, Hoffmann WE, Buck WB.
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1034-49. PubMed ID: 4092867
    [Abstract] [Full Text] [Related]

  • 19. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of some microbial and chemical transformation products of anguidine (4,15-diacetoxyscirpene-3-ol).
    Claridge CA, Schmitz H, Bradner WT.
    Cancer Chemother Pharmacol; 1979 Oct; 2(3):181-2. PubMed ID: 455572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.